People’s Pharmacy: Here’s the latest FDA update on breast implant illness
The safety of breast implants has been controversial for decades. On February 6, 2025, the Food and Drug Administration ...
People’s Pharmacy: The FDA issues update on breast implant illness
Q. Allergan ran a long-term study on silicone breast implants in 2009. I always wanted a more feminine body like the girls in the magazines, so I joined and got implants. They never followed up with ...
Pretzel Recall Update as FDA Sets Highest Risk Level'
Consuming the recalled pretzels if you have a milk allergy could cause "serious adverse health consequences or death." ...
Cookies Recall Update as FDA Sets Risk Level
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D.
Trying to eat healthy? FDA has a couple of changes to make it easier. What to know
"Under the updated 'healthy' claim, nutrient-dense foods that are encouraged by the Dietary Guidelines — vegetables, fruits, ...
STAT12h
FDA’s Troy Tazbaz returns to Oracle after a short stint shaping health AI rules
Troy Tazbaz, the outgoing director of the FDA's digital health center, is returning to Oracle as a senior vice president.
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN – – Approval based on positive data ...
FierceBiotech2d
UPDATE: RFK Jr. says HHS is 'bringing back common sense' with new messaging on 'biological truth'
While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...
‘May contain metal pieces’: FDA updates recall for granola bars sold nationwide
The U.S. Food and Drug Administration has posted an update on a granola bar recall initiated last year, labeling it as “Class ...
PharmaTher Provides Update on FDA New Drug Application for Ketamine
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company seeking FDA approval for ketamine, today announced that ...
FiercePharma7d
Astellas' eye med Izervay lands key FDA label update, amping up market battle with Apellis rival
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
Morningstar8d
PharmaTher Provides Update on FDA New Drug Application for Ketamine
The FDA requested new and updated information and ... and Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events ...